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XBP1 AND MIST1 ARE NOT SUFFICIENT TO INDUCE THE REGULATED 
SECRETORY PATHWAY IN PAROTID CELL LINES 
 
Ian S. Pyle 
 
October 1st, 2013 
 
BACKGROUND: Xerostomia causes oral infections, tooth decay, and hindered 
digestion. Crucial to oral homeostasis is the salivary proteome. How these 
proteins are trafficked through secretory cells into secretory pathways is 
unknown. Abundant in the saliva is Parotid Secretory Protein (PSP), secreted 
through the regulated secretory pathway.  
HYPOTHESIS: The addition of XBP-1 and Mist1, known for differentiation marker 
regulation, to ParC10 cells will improve stimulated secretion of PSP.  
METHODS: Fusion clones were transiently or stably transfected into ParC10 
cells. Media from non-stimulated and stimulated cells was harvested and 
luciferase activity was assayed.  
RESULTS: Stimulated secretion of cypridina-PSP was not significantly higher 
than non-stimulated secretion; suggesting cypridina-PSP did not enter the 
regulated secretory pathway. Stably transfected ParC10 showed similar results.  
CONCLUSION: Cypridina-PSP, XBP-1, and Mist1 did not show stimulated 
secretion and thus, no cell differentiation was observed. The ParC10 cells lack a 
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Xerostomia, widely known as dry mouth, is a grievous condition affecting 
hundreds of millions of people worldwide (Rudney, 1995; Ship, Pillemer, & Baum, 
2002). Dry mouth is a condition in which the flow of saliva is diminished (Chan, 
Huang, Young, & Lou, 2011; Rudney, 1995). Xerostomia can be caused by a 
number of factors or conditions, predominately: medication use, Sjögren's 
syndrome, and salivary gland damage or removal due to radiation therapy as 
cancer treatment (Baker et al., 2008; Chan, et al., 2011; Hadley et al., 2013; 
Shetty, Bhowmick, Castelino, & Babu, 2012; Su et al., 2013; Zhang et al., 2013). 
The symptoms of dry mouth are: rampant oral infections, tooth decay, 
periodontitis, hindered digestion, and difficulty swallowing, speaking, and tasting 
food (Chan, et al., 2011; Gorr, Venkatesh, & Darling, 2005; Shetty, et al., 2012; 
Zhang, et al., 2013). Though the fluid nature of saliva is important in the 
prevention of the symptoms of dry mouth, the proteins that inundate the saliva, 
produced and secreted by the parotid glands, play an essential role in host 
protection against infection, digestion, and overall oral homeostasis (Bhalla, 
Tandon, & Satyamoorthy, 2010; Heo et al., 2013; Humphrey & Williamson, 
2001). It is important to study these proteins and how they are secreted to further 
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the understanding of dry mouth, its future cure, and develop novel ways to 
alleviate its symptoms. 
The Salivary Glands and Specifically the Parotid Gland 
The salivary glands are responsible for the synthesis, storage, and 
secretion of saliva and all of its proteins. The major salivary glands are: the 
sublingual glands, the submandibular glands, and the parotid glands (Baker, 
2010; Ho, Lin, Ann, Chu, & Yen, 2011). There is also a multitude of minor 
salivary glands throughout the lower facial and upper neck region (Humphrey & 
Williamson, 2001). In humans, the parotid glands are located laterally, on either 
side of the head, and are distal to the rami of the mandible, and are anterior to 
the ears (Ho, et al., 2011). The parotid gland is made of two distinct lobes, a 
superficial lobe and a deep lobe called the pharyngeal extension (Gervasio, 
D'Orta, Mujahed, & Biasio, 2011). The superficial lobe accounts for two-thirds of 
the total parotid gland mass, and the pharyngeal extension comprises the 
remaining mass (Gervasio, et al., 2011). Though the facial nerve crosses over 
the parotid gland, it does not innervate the gland (Li, Li, Zhang, Yang, & Wu, 
2012). Rather, the parotid glands are innervated by the glossopharyngeal nerve 
(cranial nerve IX) (Gervasio, et al., 2011). The nerve innervation is solely 
autonomic and both para-sympathetic and sympathetic nerves stimulate the 
parotid gland. 
In rats, the source of the parotid gland cells used in this study, the parotid 
glands are located subcutaneously near the midline of the neck lateral to the 
trachea. Like human parotid glands, the rat glands are innervated by the 
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autonomic nervous system. Sympathetic and parasympathetic nerves stimulate 
the salivary glands to secrete salvia, which enters the mouth through ducts. The 
parotid gland duct is called Stensen’s duct. Like all salivary ducts, Stensen’s duct 
begins as a multi-branched body connecting to scores of acini, which are clusters 
of secretory cells, individually called acinar cells (Baker, 2010; Baker et al., 
2010). Generally, single acinar cells secrete saliva and its proteins into the center 
of the acinus. The saliva then enters an intercalated duct which then leads to a 
striated duct which eventually leads to the salivary duct, i.e. Stensen’s duct, and 
thus into the oral cavity. 
Saliva and Its Secretion 
Saliva is the liquid solution secreted into the oral cavity to help lubricate 
and prevent infection of the soft and hard oral tissues (Tran et al., 2013). 
Additionally, saliva helps break down food and begin the digestion process. 
Critical to the function of saliva is the multitude of proteins that are present (Heo, 
et al., 2013). 
Current research on saliva shows a salivary proteome of over 2,400 
unique proteins (Cabras et al., 2013). Of the large number of proteins found in 
the saliva, the most abundant are amylase, Parotid Secretory Protein (PSP), a 
family of acidic and basic Proline Rich Proteins, histadin, and statherin (Darling, 
2012; Helmerhorst & Oppenheim, 2007). As with all biological systems, the 
proteome of the saliva is not constant. Instead, it is quite dynamic (Helmerhorst & 
Oppenheim, 2007). From synthesis to secretion, the proteins undergo a myriad 
of changes ranging from deglycosylation, cleavage, and protein to protein 
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complex formation (Helmerhorst & Oppenheim, 2007). The protein makeup of the 
saliva is constantly changing depending on the environment of the oral cavity and 
the outer host environment. The saliva is also continually cycled as an individual 
swallows and new saliva is secreted into the oral cavity. 
The water and mucus portions of saliva are major components, but 
henceforth this research paper focuses on the proteins of saliva. Before the 
salivary proteins can enter the oral cavity, they have to be sorted within the 
individual acinar cell. Exocrine gland acinar cells have several secretion 
pathways to traffic proteins within the cell and into the extracellular environment. 
In the parotid, these distinct secretion pathways are the major regulated 
secretory pathway, minor regulated pathway, apical and basolateral constitutive 
secretory pathway, and the constitutive-like secretory pathway (Castle, Huang, & 
Castle, 2002; Darling, 2012; Perez, Rowzee, Zheng, Adriaansen, & Baum, 2010). 
This research focuses on the difference between two of these pathways, the 
apical and basolateral constitutive secretory pathway (constitutive pathway) and 
the major regulated secretory pathway (regulated secretory pathway). 
Constitutive secretion, that is secretion through the constitutive pathway, 
occurs in both the apical and basolateral ends of an exocrine cell. This type of 
secretion is continuous and the pathway is always turned on, in such a manner 
that secretion occurs regardless of the presence of a stimulus. Even when a cell 
is stimulated, the constitutive pathway is turned on and contributing to the total 
cell secretion. The proteins secreted via the constitutive pathway first enter 
secretory vesicles, which then travel directly from the trans-golgi network to the 
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extracellular membrane for exocytosis in both the apical and basolateral ends of 
the cell (Gorr, et al., 2005; Kim, Gondre-Lewis, Arnaoutova, & Loh, 2006). 
Furthermore, the proteins that enter the constitutive pathway seem to differ from 
those found in other pathways. Most likely, these constitutive specific proteins 
are used for plasma and extracellular matrix communication; both regions found 
abutting the basolateral end of acinar cells. 
Conversely, regulated secretion occurs only when the exocrine cell is 
exposed to a stimulus. In the parotid gland, the stimulus is either alpha or beta-
adrenergic neurotransmitters. Regulated secretion, also called stimulated 
secretion for the purpose of this thesis, is the release of proteins stored in dense 
core secretory granules (DCSG) and these proteins and occurs through the 
regulated secretory pathway (Kim, et al., 2006). During unstimulated secretion, 
which is through the constitutive pathway, the parotid glands produce and 
secrete about 20% of total saliva flow, the remaining secreted by the other 
salivary glands (Denny et al., 2008; Humphrey & Williamson, 2001). However, 
during stimulated secretion, the salivary flow of parotid glands increases to 50% 
of the total flow (Denny, et al., 2008; Humphrey & Williamson, 2001). Regulated 
sec Physiologically, stimulated secretion occurs during a meal, yet it is quiescent 
between meals (Huang, Castle, Hinton, & Castle, 2001). 
Parotid Gland Acinar Cells 
Cargo proteins secreted into the parotid saliva are transcribed, translated, 
sorted, stored, and secreted by the parotid acinar cells (Venkatesh, Goyal, 
Carenbauer, & Darling, 2011). These polarized cells are cone shaped and are 
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found in clusters called acini (Baker, 2010) Figures 1A, 1B. In the middle of the 
parotid acinus is the duct where the saliva is secreted into and eventually through 
the Stensen’s duct and into the oral cavity Figure 1A. Surrounding the acinar 





































Figure 1:  (A) This is a picture of an acinus (Mills, 2007). An acinar cell is 
highlighted in red and Stensen’s duct (salivary duct) is in the center of the acinus. 
(B) A cartoon of an acinar cell (Mills, 2007). (C) A cartoon of a commensurate 
acinar cell(Gorr, et al., 2005). The bold arrow lines represent the regulated 
secretory pathway. The thin arrow lines represent the other various pathways 
including the constitutive pathway. Note the constitutive pathway is multi-
directional, yet the regulated secretory pathway is uni-directional, specific to the 
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Immortalized Parotid Gland Acinar Cells (ParC10 cells) 
 Ideally, primary rat parotid gland acinar cells would be used to study 
regulated secretion. Parotid cells are highly differentiated and are specialized 
cells performing very specific functions, such as saliva protein production and 
secretion. However, primary cells are difficult to isolate and even more difficult to 
sustain for the duration of a transfection experiment. Therefore, our experimental 
model used ParC10 cells, which are immortalized rat parotid gland acinar cells 
(Quissell, Turner, & Redman, 1998). ParC10 cells are constantly used to study 
salivary gland secretion and have been studied extensively (Nelson, Manzella, & 
Baker, 2013). ParC10In addition to ParC10 cells, this thesis refers to ParC5 cells, 
although they were not used in any experiments described in the results. Though 
the two cell lines grew up in separate wells and have some morphological and 
growing characteristic differences, they are essentially the same and were 
derived from the same immortalization experiment. ParC10 cells grow well in 
polystyrene flasks and in cell culture wells, while primary cells rapidly lose the 
differentiated phenotype in culture. The immortalized ParC10 cells do originate 
from primary rat parotid gland acinar cells, but are instead undifferentiated and 
have lost expression of some crucial proteins and transcription factors (Figure 2). 
Transcription Factors Missing from ParC10 Cells 
 It is known that ParC10 cells express lower levels of RNA for proteins and 
transcription factors such as amylase and Mist1 than primary rat parotid gland 
cells (Figure 2). Mist1 is a class B basic helix loop helix transcription factor 
(Yoshida et al., 2001). Mist1 and XBP-1 are two transcription factors thought to 
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contribute to the regulation of expression of amylase (Figure 3). It is also known 
that both Mist1 and XBP-1 are important for the biogenesis of secretory granules 
and other machinery required for the regulated secretory pathway (Lee, Chu, 
Iwakoshi, & Glimcher, 2005; Tian et al., 2010). Thus, the addition of Mist1, XBP-
1, or both to ParC10 cells may help initiate biogenesis of missing machinery 



































Figure 2:  Gene Expression of Transcription Factors and Differentiation 



























Figure 2: The above graph represents RNA expression levels of Amylase, Mist1, 
PSP, and Tcf12 in primary rat parotid gland cells (violet and purple colored bars) 
and ParC5 cells (beige and ice blue colored bars). The y-axis shows the RNA 
expression levels as a 1/fold change starting from 10 at the top and going down 
10 logs to 1x10-9. ParC5 cells were derived from the same experiment as ParC10 
cells. The conclusion of this graph is RNA expression levels for Amylase, Mist1, 
and PSP are exponentially less in ParC5 cells than in primary rat parotid gland 





























Figure 3:  This figure shows a hypothetical transcription factor network. Various 
transcription factors, in black, help regulated the expression of the differentiation 
markers, in red. The hypothetical transcription factor network above suggests 
XBP and Mist1 are transcription factors involved in the expression of key parotid 
gland cell differentiation markers, amylase, PSP, and Itpr3. This is a working 





Regulated Secretory Pathway 
ParC10 cells are not polarized in culture and thus uni-directional regulated 
secretion cannot truly occur. However, the cells can be stimulated via an 
adrenergic agonist, which turns on the regulated secretory pathway in vivo. 
When the stimulant is added to ParC10 cells, for our experimental purposes, the 
operational definition of this type of secretion is:  "stimulated secretion."  
When stimulated in vivo, vesicles containing cargo proteins move to the 
apical end of the cell and the proteins are released. These specific vesicles are 
called dense-core secretory granules (DCSG). Until stimulated, these DCSGs 
are stored and continue to remain in the apical end of the cell, as seen in Figure 
1A (Arvan & Castle, 1986; Borgonovo, Ouwendijk, & Solimena, 2006). The 
DCSGs are the small dark circles located in the apical, the pointed, end of the 
cell (Figure 1A) (Borgonovo, et al., 2006).  
Contents of the DCSGs are released, via exocytosis, when Par-C10 cells 
receive a beta-adrenergic stimulus (Soltoff & Hedden, 2010). A stimulant used in 
previous literature is isoproterenol, which is a beta-adrenergic agonist for the 
neurotransmitter epinephrine. The stimulus binds to the Beta-2 adrenergic 
receptors, which turn on a G-protein and adenylyl cyclase coupled pathway, 
thereupon up-regulating cyclic-adenosine monophosphate (cAMP) and activating 
protein kinase A (PKA) (Soltoff & Hedden, 2010; Takuma et al., 2013). This in 
turn induces the PKA cascade allowing the release of DCSGs. 
Though the DCSGs are packed full of cargo proteins, only certain proteins 
are found in these vesicles (Gorr, et al., 2005). Hence, there are some cargo 
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proteins that are distinguishable and are directed specifically into the regulated 
secretory pathway and into the specific granules. How this particular “protein 
sorting” occurs and how specific cargo proteins are directed into the regulated 
secretory pathway remains unknown (Courel et al., 2010; Dikeakos & 
Reudelhuber, 2007; Folsch, Mattila, & Weisz, 2009; Lord et al., 2011). 
Cargo Proteins of the Parotid Gland 
 During stimulated secretion, the parotid glands contribute all the major 
salivary cargo proteins such as amylase, parotid secretory protein (PSP), and 
proline rich protein (PRP). These cargo proteins are transcribed and translated 
like all proteins. However, also like all proteins, after being directed into the 
endoplasmic reticulum (ER) via a signal sequence, the signal sequence of cargo 
proteins is cleaved by signal peptidase. Then protein continues to mature and 
moves to the trans-golgi network (TGN) and enters the regulated secretory 
pathway and is shepherded into secretory vesicles (Badr, Hewett, Breakefield, & 
Tannous, 2007; Folsch, et al., 2009; Sobota, Ferraro, Back, Eipper, & Mains, 
2006). It is this process, in which the cargo proteins are sorted into the regulated 
secretory pathway, that is widely unknown (Courel, et al., 2010; Dikeakos & 
Reudelhuber, 2007; Lord, et al., 2011). It is important to note that this process is 
unknown for all cargo proteins, secreted from all exocrine glands and this query 
is not limited to the parotid glands. It is currently postulated that certain proteins 
contain a sorting sequence or structure, different than the signal sequence which 
only directs the a nascent protein into the ER and is then cleaved, and it is this 
sorting sequence or structure that helps the cell recognize if the protein should 
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be directed into the regulated secretory pathway or not (Gorr, et al., 2005). 
However, it is important to note, this sequence or structure has not been found 
for proteins that enter the regulated secretory pathway, Such as PSP (Gorr, et 
al., 2005; Venkatesh, et al., 2011). 
Parotid Secretory Protein (PSP) 
Rat PSP, known as BPIFA2E, is a member of the 
bactericidal/permeability-increasing-fold (BPI-fold) protein superfamily 
(Abdolhosseini, Sotsky, Shelar, Joyce, & Gorr, 2012; Bingle & Bingle, 2011; 
Darling, 2012; Geetha, Venkatesh, Bingle, Bingle, & Gorr, 2005). This 
superfamily includes the protein families: BPI protein, lipopolysaccharide binding 
protein (LBP), phospholipid transfer protein (PLTP), and cholesteryl ester transfer 
protein (CETP) (Abdolhosseini, et al., 2012; Darling, 2012). This protein is a 
member of the palate, lung, and nasal epithelium clone (PLUNC) gene family 
and, in humans, the gene is found on chromosome 20q11 (Abdolhosseini, et al., 
2012; Bingle & Bingle, 2011). Recent research suggests human PSP is a LBP 
protein, which indicates an anti-inflammatory role (Geetha, et al., 2005). 
Additionally, it is documented that recombinant PSP shows anti-bacterial activity 
against the Gram-negative bacterium P. aeruginosa (Geetha, et al., 2005; 
Geetha, Venkatesh, Dunn, & Gorr, 2003). 
PSP is a protein secreted through the regulated secretory pathway that 
has antibacterial and anti-inflammatory properties (Geetha, et al., 2003). The 
protein is found in both human and rats, as well as pigs and bovine animals 
(Gorr, et al., 2005). PSP is only found in the saliva but not serum (Darling, 2012; 
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Venkatesh, Tan, Gorr, & Darling, 2007). Thus, PSP must enter the apical 
regulated secretory pathway since it is secreted uni-directionally out the apical 
end of the acinar cell towards Stensen’s duct and not towards the basolateral 
end of the cell.  
More evidence PSP enters the regulated secretory pathway is that it is 
found in DCSGs (Gorr, et al., 2005; Venkatesh, et al., 2011). Demonstrations 
have been made to show PSP binds to Phosphatidylinositol(3,4)bisphosphate 
(PtdIns (3,4)P2) very well (Venkatesh, et al., 2011). PtdIns (3,4)P2 is a lipid 
primarily found in the TGN and secretory granule membranes.  
Of the major cargo proteins secreted by the parotid gland, PSP is a 
primary candidate for studying regulated secretion because, in vivo, it only enters 
the regulated secretory pathway and is only secreted when stimulated. However, 
how PSP enters this pathway is unknown. Furthermore, it is unknown how any 
protein enters the regulated secretory pathway of any acinar cell. 
Hypothesis 
The goal of this research is to establish a working experimental model to 
distinguish regulated secretion from other secretion pathways. With this goal in 
mind, we can use this experimental model to study how the specific salivary 
protein PSP enters the regulated secretory pathway. Considering that ParC10 
cells lack transcription factors important to the function of the regulated secretory 
pathway, an important goal is to increase their expression and presence in the 
cells. The hypothesis is that the addition of XBP-1 and Mist1 to ParC10 cells will 







The overall approach was to tag PSP with luciferase enzymes, making a 
quantitative and sensitive way to measure PSP secretion. It was necessary to 
synthesize DNA plasmid clones in the laboratory to construct the unique fusion 
proteins for our transfection experiments. The plasmid vectors were designed 
using Vector NTI software, which showed possible enzyme cut sites and the 
primers needed. The desired DNA fragments, were amplified by PCR (MJ 
Research PTC-200 thermocycler). This process consisted of 6 minutes of 
denaturation at 95º C, 33 cycles of 95º C, 58º C and 72º C, and an extension 
time of 10 minutes at 72º C. The PCR product was confirmed by agarose gel 
electrophoresis and then cut out of the gel and purified using a Qiagen QIAquick 
Gel Extraction Kit. 
Then, the purified PCR product was digested with appropriate enzymes, 
specific to the DNA fragment and the vector, and ligated into the vector using the 
thermocycler. The vectors were then transformed separately into Invitrogen One 
Shot Top10 chemically competent bacterial E. coli cells. The cells were put onto 
a Luria Bretani broth (LB)/agar plate with ampicillin and left to incubate overnight 
at 37º C. Colonies were picked and placed on a master plate and inoculated in 
10 mL of LB/ampicillin media over night in a shaker at 37º C. The following day a 
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miniprep (Promega Wizardplus SV Miniprep kit) was performed per the 
manufacturers instructions to purify the plasmids. The plasmids were then 
digested with an enzyme or enzymes to cut the vector in a way to easily identify 
whether the DNA fragment was ligated correctly into the vector. This process 
usually produced a small and large fragment, which produces bands easy to 
distinguish on a gel. The successful plasmids were then sequenced at the 
University of Louisville Nucleic Acid Sequencing CGeMM core. Once the 
sequences were verified, the colonies with the correct sequences were picked 
from the master plate and inoculated in 50 mL of LB/ampicillin media overnight in 
a shaker at 37º C. The plasmids were purified using a QIAgen Plasmid Midi Kit. 
The final plasmids were sampled in a nanodrop machine to verify no protein 
contamination, (!260/280 >1.80) and the amount of DNA in ng/!L. 
ParC5 Media Solution 
 The optimal solution for culturing ParC10 cells is ParC5 media, identical to 
the media used for culturing ParC5 cells. One liter of ParC5 media solution 
contains: 950 mL double-distilled H20; 10 mL of insulin-tranferrin-selenium-X 
(Invitrogen); 1 mL of 1 mM hydrocortisone; 30 !L of 1 mg/mL retinoic acid 
solution; 20 !L of 0.1 mM T3 solution; 50 !L of 1.0 mg/mL EGF, 1 mL of 200 mM 
L-Glutamine, 1 mL of 50 mg/mL gentamicin; 1 mL of Trace Element Solution 
(MPBiomedical); 5 mL of Penn/Strep (Invitrogen); 25 mL of fetal bovine serum 
(FBS); 1.25 g of NaHCO3; and 15.6 g of Dulbecco's Modified Eagle Medium-F12. 




 ParC10 cells were grown in either a T-25 or T-75 flask in either 5 or 10 mL 
of ParC5 media respectively. During growth, the media was exchanged for fresh 
media dependant on the pH, determined by color of media, or amount of debris 
found in the flask. Cells were passaged when 60-75% confluent. To passage the 
cells, the flask was moved to a sterile Forma Scientific laminar flow hood. The 
media was aspirated, and 1mL or 0.5mL of trypsin was added to a T-75 flask or 
T-25 flask, respectively. The flask was moved to a New Brunswick Scientific 
Excella Eco 170 incubator with 5% CO2 and a temperature of 37° C, and 
incubated for 4 minutes. 3 or 1.5 mL of ParC5 media was added to the T-75 or T-
25 flask respectively and the cell-containing solution was pipetted up and down 
to break up the cells. A sample of the cell solution was then stained with 50% 
trypan blue and counted using a Reichart Bright-Line hemocytometer while 
looking through an Olympus CK2 microscope set at 10X magnification. The 
resulting cell count was then calculated for cells per mL and the desired cell seed 
amount was placed into wells. A sample of the cell solution was placed into a 
new flask to complete the passaging process and begin growing a new passage 
number of cells. 
Transfection 
500 !L of ParC5 media was placed in each well of a sterile 24 well plate 
(Corning 15.6 mm diameter wells). ParC10 cells were passaged and counted 
and were seeded at either 30 k or 20 k cells per well, depending on the particular 
experiment. The cells were allowed to incubate at 37° C overnight with 5% CO2. 
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The following day, the media was changed and fusion-protein-expressing 
plasmids were diluted in Dulbecco's Modified Eagle Medium (DMEM) to the 
appropriate amounts for a total of either 500 ng or 200 ng of DNA per well. For 
control, pBluescript II KS (+) was used as a filler DNA to maintain a consistent 
DNA mass.  The plasmids were then added to the wells along with a transfection 
lipid reagent, either lipofectamine® or FuGENE HD ®. FuGENE HD ® was used 
in a ratio of 1:8, DNA to lipid reagent, respectively. The cells were allowed to 
incubate at 37° C overnight in the incubator with 5% CO2. The following day, the 
media was aspirated and the cells were prepared for a media harvest. 
Transfection Media Harvest 
The cells were washed with ParC5 media five times; incubated at 37° C 
with 5% CO2 for 5 minutes three times, then again for 30 minutes, and once 
more for 5 minutes. The final wash media was aspirated and ParC5 media was 
then added to the cells and the plate was incubated at 37° C with 5% CO2 for 
thirty minutes. Following the incubation, 400!L of the media was collected as a 
basal secretion sample. The sample was centrifuged at ~300 g for 10 minutes to 
pellet any stray cells. 300 !L of the top basal secretion sample was collected into 
a 1.5 mL Eppendorf tube and stored in 4° C until assay. The remaining 100 !L of 
media in the 24 well plate was aspirated and the 500 !L of Parc5 media was 
added to each well and the plate was incubated at 37° C with 5% CO2 for five 
minutes for a wash. The wash media was aspirated and 500!L of ParC5 media 
containing a stimulant was added to each well. The stimulated media was 
prepared by adding isoproterenol (30 !M), forskolin (10 !M), carbachol (100 
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mM), or a combination of these stimulants. Isoproterenol is an epinephrine 
agonist and turns on the cAMP pathway by binding to the beta-adrenergic 
receptor, a cellular membrane surface protein. Similarly, forskolin, turns on the 
cAMP pathway, but within the cell. The plate was incubated at 37° C with 5% 
CO2 for thirty minutes. Following the incubation, 400 !L of the media was 
collected into a 1.5 mL Eppendorf tube as a stimulated secretion sample. The 
sample was spun at ~300 g for 10 minutes to pellet any stray cells. 300 !L of the 
top stimulated secretion sample was collected into a 1.5 mL Eppendorf tube and 
stored at 4° C until assay  
Assay 
To assay the samples of a media harvest, 20 !L amounts of each 
harvested media sample was loaded onto a Perkin-Elmer 96 well OptiPlate in 
duplicate.  A Berthold Centro XS3 LB 960 Luminometer was washed with 70% 
EtOH and dionized H2O and then primed with either cypridina or gaussia 
luciferase reagent. The relative light unit (RLU) data were displayed and 
recorded using MikroWin 2000 software. 
Stable Cell Creation 
 To create the stable cell lines, the desired genes, i.e. Cypridina-PSP, 
Cypridina (Cluc-2), XBP, and Mist1 were cloned into the PBQM812-A1 PiggyBac 
Tranposon system vector (System Biosciences). The PiggyBac Transposon 
system transposes its cloned-in gene into the genome of the transfected cell. 
Gene expression can be turned on in the presence of cumate and turned off 
when the cumate is removed via the cumate switch. The PiggyBac system also 
 21 
transposes a puromycin resistant gene, so successfully transfected and 
transposed cells will live in the presence of puromycin. Finally, the system 
includes a GFP expressing gene, turned on in the presence of cumate. This 
feature gives the user the ability to see successful transposition using a confocal 
microscope. 
 Once the Cypridina-PSP, Cluc-2, XBP, and Mist1 PiggyBac plasmids were 
cloned, they were transfected into ParC10 cells, alone or in combination; 
including an empty PiggyBac plasmid for a control. The lines and their respective 
combinations are listed in the Results section. The cells were then put through a 
series of increasing puromycin concentrations to select for the successfully 
transfected and transposed cells. Ultimately, the cell lines were checked for 
successful transposition via the confocal microscope. Then, they were placed in 
liquid nitrogen tanks for long-term storage, or used immediately for secretion 
experiments. 
Stable Cell Secretion Experiment 
The cells were initially plated at 30 k cells per well. The cells were grown 
in regular ParC5 media for six hours. Then, the media was aspirated and fresh 
ParC5 media containing 3 !g/mL of Puromycin and 10 !g/mL of Cumate was 
added until the cells were ready for harvest. The puromycin is necessary 
because the PiggyBac vector transposes a puromycin resistant gene to help 
select for just stably transfected cells. The Cumate in the media turns on the 
Cumate Switch vector so the cells can begin expression of the protein or proteins 
inserted into the cell. 
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rtPCR  
Reverse transcriptase was performed using the High Capacity cDNA Reverse 
Transcriptase Kit from Applied Biosystems per the manufacturer’s instructions. A 
control tube was made without the reverse transcriptase enzyme. The results 
were verified on an agarose gel. 
Preparation of Agarose Electrophoresis Gel 
DNA samples were analyzed using gel electrophoresis. 1% agarose 
electrophoresis gels were made by combining 40 mL of double de-ionized water, 
10 mL of 5x Tris/Borate/EDTA (TBE) buffer, and 0.5 g of ME agarose in an 
Erlenmeyer flask. The mixture was heated in an Amada RadaRange microwave 
oven for 2 minutes, pausing to swirl the flask at 30-second intervals. After 
warming, 6 uL of ethidium bromide was added to the mixture and it was then 
poured into the gel apparatus. A gel comb was inserted to create slots in the gel 
and the mixture was left to cool and harden. Once solid, 6x-loading dye was 
added to each sample and then samples and 1kb+ molecular weight marker DNA 
ladder (Invitrogen) were added into the gel slots. The gel was run using a 
FischerBiotech 105 electrophoresis system set to 148, or 48 volts for low melt 
gels, and left for 30minutes to 2 hours. For analysis, gels were placed on a 
Fishcer Biotec FBTI 816 312 nm ultraviolet transilluminator and the picture was 









Synthesis of Clones used for Transient Transfections 
The ability to measure a specific protein being secreted out of an exocrine 
cell was crucial to designing the experiments used in this research. The other key 
was using a secreted protein well known for a specific secretion pathway. 
Luciferase proteins, which are readily attached to other proteins via cloning, emit 
light when interacting with specific substrates, e.g, luciferin and ATP. The light 
produced from the luciferase protein and substrate interaction can be easily 
measured. Thus, a luciferase protein was attached to Parotid Secretory Protein 
(PSP), which is well documented for only entering the regulated secretory 
pathway in parotid gland cells, as mentioned in the introduction. Clones are 
inserted into cells by performing a transient transfection. The clone is part of a 
plasmid vector, which enters the nucleus of a cell to be transcribed and 
translated. After secretory cells manufacture this fusion protein, it is then 
secreted into the culture media and the amount of released protein is measured. 
The cells used in the following experiments were ParC10 cells. Though 
these cells were derived from a rat parotid gland, they had been immortalized 
and are to a great extent, undifferentiated. They are polar when grown on trans-
well filters. In vivo, PSP is secreted through the regulated secretory pathway, but 
in the ParC10 cells the pathway for secretion of the fusion protein is unknown. 
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Despite being undifferentiated, adding a neurotransmitter agonist to the cells may 
stimulate them to secrete the fusion protein in a more in-vivo like manner. 
Particularly, the amount of PSP being secreted should increase once a stimulus 
has been added. We used the term “stimulated” when the neurotransmitter 
agonist was added to the cells. When no stimulant was present, we used the 
term “basal,” because in-vivo, constitutive secretion occurs perpetually and at 
lower amounts. Therefore, basic cell functions critical to our research can be 
controlled and manipulated. 
The specific luciferase proteins we used in our transfections are Gaussia 
luciferase and Cypridina luciferase. Gaussia luciferase originates from the 
copepod called Gaussia Princeps (Welsh, Patel, Manthiram, & Swartz, 2009). It 
is a marine crustacean that glows from bioluminescence, caused by the Gaussia 
protein interacting with a substrate. Similar to the Gaussia protein is Cypridina 
luciferase. Cypridina originates from the ostracod called Cypridina noctiluca and 
produces a bioluminescent protein like the Gaussia protein, which also glows in 
the presence of a substrate (Nakajima, Kobayashi, Yamagishi, Enomoto, & 
Ohmiya, 2004). 
The clones and their respective plasmid vectors used for all transient 
transfections are listed in Table 1 and Figure 4. The corresponding protein 
names are listed in column 4 of Table 1. Each clone in Table 1 displays the 
correct sequence and was transformed into One Shot Top10 chemically 




Table 1   
 




Table 1:  The clones listed in table 1 are represented as diagrams in Figure 4. 
“SS” refers to the signal sequence of the protein and “"SS” refers to the deletion 












VECTOR INSERT FINAL CLONE PROTEIN NAME 
pcDNA 6.2 PSP-Gaussia ratPSP-Gaussia PSP-Gau 
pcDNA 6.2 SS-rPSP-"SS-Gaussia pcDNA 6.2-ratSSp- "SSGAU  SSp"SSgau 
pCMV Gaussia pCMV-Gluc Gluc 
pcDNA 6.2 rPSP-"SS-Cypridina pcDNA 6.2-ratPSP-"SS PSP-"SS-CLuc-2 
pcDNA 6.2 SSp-"SS-Cypridina pcDNA 6.2-SSratPSP-"SS-CLuc-2 SSp-"SS-CLuc-2 
pcDNA 6.2 Cypridina-"SS-rPSP pcDNA 6.2-CYP-"SSratPSP CYP-"SS-PSP 
pCMV CLuc-2 (Cypridina) pCMV-CLuc-2 CLuc-2 
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Figure 4. The above figure represents the various fusion proteins used for the 
transient transfections performed for this research paper. The expression vectors 
and final protein names can be found listed in Table 1 and each clone shares the 
same common letter identifier. The proteins fused to the C terminus of other 
proteins are without their signal sequence (SS). 
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Measuring Regulated Secretion 
 Regulated secretion is defined as the release of intracellular and vesicle 
bound proteins or chemicals to the extracellular space via the regulated secretory 
pathway. To interpret regulated secretion numerically, the stimulated relative light 
unit (RLU) values were divided by the unstimulated RLU values, and the resulting 
quotient is a ratio, which can help interpret the difference between basal and 
regulated secretion. Additionally, the ratio derived (stimulated divided by 
unstimulated) controls for well-to-well variation for transfection efficiency since 
each experiment is run with triplicate wells. The analyses of the experiments in 
this paper define basal secretion, as a ratio of one because the basal secretion 
divided by itself is one. Conversely, stimulated secretion is operationally defined 
as a value higher than one. Stimulated secretion if present always includes the 
perpetual constitutive secretion, which never turns off, even if stimulated. Thus, 
stimulated secretion is any ratio higher than one, while one is equal to the basal 
secretion.  
Figure 5 represents a hypothetical graph representing the raw data from a 
secretion experiment. Both the basal and stimulated raw values (RLU or relative 
light units) are shown for Cypridina-PSP and the negative control, Cypridina 
alone (CLuc-2). The important point to note is the values for both the basal and 
stimulated CLuc-2 are equal. However, the values for the basal and stimulated 
Cypridina-PSP differ; basal Cypridina-PSP is lower and stimulated Cypridina-
PSP is higher by four fold. 
 28 
 Figure 6 represents a hypothetical graph based on the graph in figure 5. 
Figure 6 displays the ratio, the result of dividing the stimulated RLU by the basal 
RLU for both Cypridina-PSP and Cypridina alone. In Figure 6, the Cypridina 
alone ratio is one, because the stimulated value is equal to the basal value. In 
theory, the stimulated Cypridina alone RLU value represents only basal secretion 
because the stimulus does not evoke a response form the regulated secretory 
pathway, but basal secretion continues regardless of the presence of a stimulus. 
Though the Cypridina alone expressing cells are stimulated, the Cypridina alone 
protein only enters the perpetual constitutive pathway and not the regulated 
secretory pathway. Conversely, the ratio of stimulated Cypridina-PSP RLU 
divided by basal Cypridina-PSP RLU equals four, because the stimulated value 
is about four times the quantity of the basal value. Thus, the stimulus does evoke 
a response in the regulated secretory pathway, and the basal secretion continues 
regardless of the presence of a stimulus. 
In the graph in Figure 6, a green line set at the basal/stimulated ratio of 
one represents the defining point at which the secretion occurring is either basal, 
below the green line, or stimulated, above the green line. Since Cypridina-PSP 
shows a ratio above one and above the green line, basal and stimulated 
secretion is occurring. Since Cluc-2 shows a ratio of one, and an average just at 





Figure 5:  Hypothetical Raw Transfection Data
 
 
Figure 5:  Theoretical transfection data of a comparison between the negative 
control Cluc-2 (blue), and the experimental variable Cyp-PSP (red). (N = 3) In 
this hypothetical experiment, both the basal and stimulated results of the 
negative control have similar RLU values of 1.2 million. Conversely, the 
stimulated values for Cyp-PSP, five million, are much higher than the basal 






Figure 6: Hypothetical Stimulated / Basal Ratio Data 
 
Figure 6:  The stimulated RLU values were divided by their basal analogues, and 
the quotient is a ratio, which can help interpret the difference between basal and 
regulated secretion. Basal secretion is defined as a ratio of one. Stimulated 
secretion is operationally defined as any value higher than one. It is important to 
note that basal secretion is always occurring, even when stimulated secretion is 
observed. Cluc2 has a ratio of exactly one, suggesting only basal secretion is 
occurring. Cyp-PSP has a ratio of four, suggesting regulated secretion is 




Using Gaussia as a luciferase tag 
The goal of this series of experiments was to find a way to distinguish 
between basal and stimulated secretion. The hypothesis was the PSP-Gaussia 
would show stimulated secretion, while the negative control, the fusion protein of 
just the signal sequence of PSP and gaussia (SSp-#SSgaussia), would show no 
stimulated secretion, just basal secretion while stimulated.  
Triplicate wells, each initially seeded with 45 k ParC10 cells, were each 
transfected with 100 ng of the fusion protein clone Gaussia-PSP. In the same 
manner, triplicate wells were each transfected with 300 ng of the fusion protein 
Gaussia-PSP. Likewise, triplicate wells, each initially seeded with 45 k ParC10 
cells, were each transfected with 100 ng of SSp"SS-Gaussia, the negative 
control. A fourth set of triplicate wells, each initially seeded with 45 k ParC10 
cells, were each transfected with 300 ng of SSp"SS-Gaussia. An additional, 20 
ng of CLuc-2, the transfection efficiency measure, was transfected into each well. 
To maintain consistency, the filler DNA pBlueScript II KS (+) was used to bring 
the total amount of transfection DNA for each well to 500 ng. Lipofectamine™ 
2000 (Invitrogen) was used as the lipid transfection reagent.  
The transfection was performed with a series of washes and the basal and 
stimulated media were applied and collected after thirty minutes consecutively. 
An assay was performed by first loading 20 !L of each media sample into 12 x 
75 mm borsociliate glass tubes in duplicate. Then, the gaussia and cypridina 
luciferase solvent, buffer, and substrate solutions were made and loaded into the 
luminometer. The assay was performed in a Berthold Lumat 9501 luminomter. 
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The average of the three transfection experiments showed both basal and 
stimulated secretion are occurring for 300 ng of SSp-#SSgaussia Figure 7. 
However, the average of 100 ng of SSp-#SSgaussia is right at the green line and 
thus only basal secretion is occurring Figure 7. 
The conclusion is SSp#SSgaussia, the negative control may show 
regulated secretion. Thus, it is a poor negative control. Additionally, Gaussia 
could be the protein with a sorting sequence directing the fusion protein into the 
regulated secretory pathway, and this would make it more difficult to discover the 
sorting sequence on the PSP protein, with the interference of Gaussia. It is 
important to note, while SSp#SSgaussia has the signal sequence of PSP on the 
N-terminus, the signal sequence is cleaved by signal peptidase as the protein 
enters the endoplasmic reticulum (ER). Thus, the mature gaussia protein was 
showing potential stimulated secretion without the influence of PSP. An unbiased 











Figure 7:  Gaussia-PSP Shows no Stimulated Secretion 
Figure 7:  The graph above represents the average stimulated / basal ratio for 
three different secreted proteins, the corresponding genes being transfected into 
the cells. The bars represent an N of 1 to 3. Gaussia-PSP showed no stimulated 
secretion for both the 100 ng and 300 ng transfected amounts. Likewise the 100 
ng of gaussia with the PSP signal sequence attached did not show stimulated 
secretion either. The 300 ng of SSp"SSgaussia showed variable but higher 
secretion, which may include some stimulated secretion, though the standard 
deviation was quite large. Lastly, the gaussia only showed no stimulated 
secretion. 
 
     SSp 
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Using Cypridina as a luciferase tag 
The transfection efficiency measure protein Cypridina did not show 
regulated secretion and therefore was used to make a new luciferase fusion 
protein with PSP Figures 4D, E, & F. Cypridina was attached to PSP in two 
variants. The first variant was Cypridina attached to the C-terminus of PSP (PSP-
Cypridina) Figure 4D and second, cypridina attached to the N-terminus of PSP 
without its signal sequence (Cypridina-PSP) Figure 4F. The two variations are 
necessary because one or the other might allow the protein to fold in a way to 
prevent the protein from entering the regulated secretory pathway. PSP from 
primary cells is not a fusion protein and the attached cypridina might affect the 
fold of PSP. Therefore, of the two versions synthesized, one of the recombinant 
proteins may be more efficient than the other in entering the regulated secretory 
pathway and will be more similar to the in-vivo PSP protein expressed in primary 
cells. Furthermore, the signal sequence of PSP was attached to the N-terminus 
of Cypridina (SSp#SSCypridina) as a negative control for future experiments 
Figure 4E. 
The goal of the following series of experiments was to distinguish between 
basal and stimulated secretion using a fusion protein of PSP and Cypridina. The 
hypothesis was that cypridina-PSP fusion protein would enter the regulated 
secretory pathway while the control cypridina protein would not enter the 
pathway.  
Triplicate wells, each initially seeded with 45 k ParC10 cells growing in 
ParC5 media, were each transfected with 100 ng or 300 ng of the fusion protein 
 35 
Cypridina-PSP. Likewise, triplicate wells, were each transfected with 100 ng or 
300 ng of PSP-Cypridina. A fifth set of triplicate wells, were each transfected with 
300 ng of PSP-Cypridina. Additionally, 50 ng of CLuc-2, was transfected into 
triplicate wells. To maintain consistency, the filler DNA pBlueScript II KS (+) was 
used to bring the total amount of transfection DNA for each well to 500 ng. The 
Lipofectamine™ 2000 (Invitrogen) was used as the lipid transfection reagent.  
The transfection was performed with a series of washes and the basal and 
stimulated medias were applied and collected after thirty minutes consecutively. 
An assay was performed by first loading 20 !L of each media sample in duplicate 
onto a 96-well microplate. Then, the Cypridina luciferase solvent, buffer, and 
substrate solutions were made and loaded into the luminometer and the assay 
was run. 
The 300 ng of Cypridina-PSP fusion protein, the Cypridina luciferase tag 
is on the N-terminus of PSP sans the signal sequence, showed some stimulated 
secretion (Figure 8). The 100 ng of Cypridina-PSP and the 100 ng and 300 ng of 
PSP-Cypridina did not show stimulated secretion. In addition, in Figure 8, the 50 
ng of Cluc-2, the negative control, did not show stimulated secretion either. 
Though an increase in Cyp-PSP was observed, an ANOVA test showed no 
significance. Since the Cypridina-PSP fusion protein seemed more efficient than 
PSP-Cypridina with a higher stimulated / basal ratio, it was then used for all 
future transfection experiments. Though 300 ng of Cypridina-PSP showed some 
stimulated secretion, the standard error was still large, so the transfection 
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efficiency was scrutinized and a change in the transfection reagent was made for 
the following transfection experiments. 
In the previous transfection experiments, lipofectamine was used as a 
lipid transfection reagent. However, considering the high rate of cell mortality and 
low transfection efficiency of lipofectamine, a different lipid transfection reagent, 
FuGENE HD ® (Promega), was used for transfection #13 and all transfections 
thereafter. The conditions were optimized, and for all transfections using 
FuGENE HD ® (Promega) the total amount of DNA was 200 ng for each well. 
With the same goal of distinguishing between basal and stimulated 
secretion, another set of experiments was carried using FuGENE HD ® 
(Promega) as the transfection reagent. The transfection setup was similar using 
100 ng of Cypridina-PSP and either 25 ng or 2.5 ng of Cluc-2 each transfected 
into one well of triplicate ParC10 cells. The harvest was carried out in an identical 
manner. 
In Figure 9, the aggregation of transfections thirteen through nineteen 
show Cypridina-PSP with an average stimulated / basal ratio of 1.25. The 
average stimulated / basal ratio of SSp#SS-CLuc-2 was 1.05. The aggregation of 
transfections fourteen through nineteen show Cypridina-PSP with an average 
stimulated / basal ratio of 1.2. Similarly, the average stimulated / basal ratio of 
SSp#SS-CLuc-2 was 1.0. None of the averages were statistically significant 
based on a paired t-test which had a p-value of 0.12 with N = 7. The conclusion 
of this data is that no stimulated secretion is being observed for the Cypridina-
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Figure 8: Cypridina-PSP and PSP-Cypridina Show No Stimulated Secretion  
Figure 8:  Regarding transfections 8, 9, & 10, Cyp-PSP and PSP-Cyp displayed 
some regulated secretion when compared to the negative control Cluc-2. 























Figure 9:  In transfections 13-19 Cyp-PSP was not significantly higher than the 
control, 25 ng of SSp"SScyp, and no regulated secretion was observed. A paired 







SSp"SS-CLuc-2 25 ng 
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Addition of Chromogranins to the transfection 
In the previous experiments, Cyp-PSP alone did not show regulated 
secretion and was never statistically significant from the controls, either Cypridina 
alone or SSp"SScyp. Since ParC10 cells are undifferentiated, the addition of 
some components present in primary cells might further differentiate the cells 
and bolster the regulated secretory pathway. It is known that chromogranins A 
and B are involved in the condensing of cargo proteins into granules and granule 
formation in primary rat parotid gland cells (Hosaka et al., 2004; Koshimizu, 
Cawley, Kim, Yergey, & Loh, 2011). The goal of the following experiments was to 
add chromogranins to help secretory granulogenesis, granule formation, and 
thus increase the likelihood of seeing stimulated secretion (Inomoto et al., 2007; 
Koshimizu, et al., 2011; Koshimizu, Kim, Cawley, & Loh, 2010). The hypothesis 
is that cells transfected with both Cypridina-PSP and chromogranin B (CgB) will 
show better stimulated secretion than cells transfected with just CLuc-2. 
100 ng of the fusion protein Cypridina-PSP was transfected into ParC10 
cells as described. 25 ng of Cluc-2 was transfected into ParC10 cells growing in 
triplicate wells. 100 ng of Cypridina-PSP and 50 ng of CgB were transfected into 
ParC10 cells growing in triplicate wells. 25 ng of Cluc-2 and CgB were 
transfected into ParC10 cells. To maintain consistency, the filler DNA pBlueScript 
II KS (+) (Stratagene) was used to bring the total amount of transfection DNA for 
each well to 200 ng. FuGENE HD ® (Promega) was used as the lipid transfection 
reagent.  
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Though the average stimulated / basal ratios of Cypridina-PSP with CgB 
were slightly above Cypridina-PSP by itself (1.5 and 1.25 respectively), the 
standard error was too great for any statistical significance (Figure 10). An 
ANOVA was performed and no statistical significance was observed based on a 
p-value higher than 0.05. Likewise, Cluc-2 and CgB together had a slightly higher 
stimulated / basal ratio than Cluc-2 alone (1.4 and 1.3 respectively), but there 
was no statistical significance (Figure 10). The conclusion from this set of data is 
Cyprdina-PSP transfected with CgB does not show more or any stimulated 
secretion than just Cypridina-PSP transfected alone. Also, Cluc-2, the negative 
















































Figure 10: The above graph represents an average of the means of the 
stimulated / basal ratio of transfections 22, 23, & 24. The average of Cypridina-
PSP with CgB was slightly higher than Cypridina-PSP without CgB, but the 
standard error was too large for any significant difference. Similarly, the average 
of Cluc-2 with CgB was slightly higher than Cluc-2 without CgB, but the standard 
error was too large for any significant difference. An ANOVA test confirmed there 
was no statistical significance between any of the bars with a p-value higher than 
0.05. 
 
Cypridina-PSP +  + -   - 
Cluc-2 -  - +   + 















Using Forskolin as the Stimulant 
 Considering the lack of regulated secretion observed in prior experiments, 
the isoproterenol could be insufficient for the observation of a robust secretion 
reaction. This thought was emphasized due to the use of trypsin (0.25%) to 
passage and plate cells. Trypsin hydrolyses the outer cellular membrane proteins 
by cleaving arginine and lysine amino acid residues. The targeted proteins to be 
hydrolyzed are cell adhesion proteins, but trypsin also hydrolyses other proteins 
on the outer cell surface such as the beta-adrenergic receptors, which bind 
isoproterenol. Hence, in the past experiments, the possible lack of isoproterenol 
binding receptors may have prevented a significant and in vivo-like stimulation 
reaction. An alternative stimulant to isoproterenol is the stimulant forskolin, which 
activates the same cAMP pathway as isoproterenol, but does so intracellularly. 
 The transfection experiments were carried out in a similar manner as 
previous. Triplicate wells, each initially seeded with 45 k ParC10 cells growing in 
ParC5 media, were each transfected with 100 ng of the fusion protein Cypridina-
PSP. Likewise, triplicate wells, were each transfected with 25 ng of Cluc-2. To 
maintain consistency, the filler DNA pBlueScript II KS (+) was used to bring the 
total amount of transfection DNA for each well to 200 ng. The FuGENE HD ® 
(Promega) was used as the lipid transfection reagent. 
 The aggregate of transfections thirty through thirty-four showed the 
stimulated / basal ratio for Cyp-PSP to be 1.2 and Cluc-2 to be 1.1 (Figure 11). 
However, a t-test gave a p-value of 0.29, thus there was no statistical 
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significance between the two. Thus, no stimulated secretion was seen for either 























Figure 11: Forskolin Does Not Improve Stimulated Secretion 
 
Figure 11:  In transfections 30 – 34, Cyp-PSP did not demonstrate regulated 
secretion with an average stimulated / basal ratio of 1.2. Similarly, the negative 
control SSp"SScyp did not demonstrate regulated secretion with an average 
stimulated / basal ratio of 1.1. The data was analyzed using a t-test, N=5, p=.29 






Cypridina-PSP 100 ng      SSp"SScyp 25 ng 
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Stable Cell Lines 
 The previous transient transfections showed little to no stimulated 
secretion and in many instances the negative control showed similar results to 
the experimental variable. Even with the addition of chromogranins, known for 
their role in dense core secretory granule formation, little to no stimulated 
secretion was observed. The cells used, ParC10 cells, are also known for lacking 
differentiation. Instead of performing more transient transfections, stable 
transfections might help the ParC10 cells to differentiate further by adding XBP 
and Mist1.  
The vector used to create the stable cell lines is a cumate induced 
piggybac transposon system. Plasmid maps of the five clones inserted into the 
piggybac vector and used in stable cell creation are shown in Figure 12. The 
clones used for stable cell secretion experiments are listed in Table 2. The 
protein or proteins expressed in each line are listed in the fourth column of Table 
2. 
Stable cell lines were created to induce differentiation of the ParC10 cells. 
Stable cell lines also reduce the secretion experiment time because the cells 
already contain the recombinant DNA, which has been integrated into the cell’s 
genome, as opposed to a transfected plasmid. Seven different cell lines were 
made using Cypridina-PSP, Cluc-2, transcription factors XBP and Mist1, and one 

























Figure 12:  The Cyp-PSP, Cluc-2, Mist-1, and XBP cDNA fragments were cloned 





Table 2:   
Stable Cell Lines and the Genes they Contain 
 
Cell Line: Mixed or Isolate Transfected Genes: Protein Name 
A Mixed Cyp-PSP Cyp-PSP 
B Mixed Cyp-PSP Cyp-PSP 
C Mixed Cypridina CLuc-2 
D Mixed Cyp-PSP, XBP, Mist1 Cyp-PSP, XBP, Mist1 
E Mixed Cyp-PSP, XBP, Mist1 Cyp-PSP, XBP, Mist1 
E2 Isolate Cyp-PSP, XBP, Mist1 Cyp-PSP, XBP, Mist1 















Stable Line Secretion Harvest, Cyp-PSP as experiment and Cypridina as 
Negative Control 
 
 The goal of the following series of experiments was to observe stimulated 
secretion and distinguish it from basal secretion. The hypothesis is that 
stimulated secretion will be seen with the E2 cell line, and only basal secretion 
will be observed with the C cell line, the negative control. 
 The secretion experiment was setup similarly to the previous transient 
transfections, but the initial cell count was reduced to 30 k cells per well. The 
cells were grown with regular ParC5 media for six hours, and then the media was 
changed to ParC5 media containing puromycin and cumate. The puromycin is to 
maintain only transposed cells, for the inserted cassette contains a puromycin 
resistance gene. The cumate is used to turn on the expression of the clone 
transposed into the genome. After the cells grew to ~70% confluence, the 
secretion harvest was performed with a series of washes, and the basal and 
stimulated media was collected after thirty minutes consecutively. An assay was 
performed by loading 20 !L of each media sample in duplicate into a 96-well 
microplate. Then, the cypridina luciferase solvent, buffer, and substrate solutions 
were made and loaded into the luminometer and the assay was run. 
 The E2 cell line showed an average stimulated / basal ratio of 1.4 and the 
C cell line (Cypridina only) showed an average stimulated / basal ratio of 1.25 
Figure 13. An unpaired T-test of these two averages showed no significant 
differences. A different series of experiments was run using isoproterenol (30 
!M), forskolin (10 !M), or both stimulants together (Figure 14). The average 
stimulated / basal ratios for the E2 cell line using IPR, Forskolin, or both was 2.4, 
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2.0, and 2.0 respectively. The average stimulated / basal ratios for the C cell line 
using IPR, Forskolin, or both was 1.8, 1.4, and 1.3 respectively.  After performing 
a two-tailed paired t-test between each pair of E2 and C cell lines stimulated 


































Figure 13:  The graph above represents the average of the means of the 
stimulated / basal ratio of secretion experiments 17, 18, and 19, using stable cell 
lines. Cell line E2 did show an average ratio of 1.4, indicating stimulated 
secretion, but the standard error was too great for significance over the Cell line 
C control. A paired two-tailed t-test was performed and yielded a p value less 
than .05, but due to the variation among separate experiments, an unpaired t-test 

















Figure 14:  
The graph above represents the average of the means of the stimulated / basal 
ratio of secretion experiments 20, 21, 23, & 25, using stable cell lines. Cell line E2 
showed stimulated secretion with a stimulated / basal ratio of 2 or over for each 
stimulant setup of IPR alone, Forskolin alone, or a combination of both. However, 
cell line C also showed some stimulated secretion when either IPR or forskolin 
were used alone. Cell line C did not show stimulated secretion with the 
combination of both stimulants. Nevertheless, based on a two tailed paired t-test 
the differences between cell line E2 and its correspondingly stimulated control, 
cell line C, were never statistically significant, the p-value was more than 0.05 





Addition of XBP and Mist1 to help differentiate ParC10 cells 
Due to the lack of differentiation of immortalized ParC10 cells, the lack of 
normal expression of crucial proteins may be preventing the primary cell-like full 
function of the regulated secretory pathway. The expression of the transcription 
factor Mist1 is abated in ParC5 cells, when compared directly to primary rat 
parotid gland cells Figure 2. Thus, reintroducing XBP-1 and Mist1 to ParC10 cells 
may help make the regulated secretory pathway become more robust and 
facilitate regulated secretion of Cypridina-PSP. Using stable cell lines to 
reintroduce XBP-1 and Mist1 to ParC10 cells is important because the cells 
express these transcription factors for a longer period of time during a stable 
transfection secretion experiment than if transiently transfected. 
The goal of this series of experiments was to determine if the presence of 
XBP and Mist1 transcription factors help increase stimulated secretion. The 
hypothesis was the D, E, and E2 cell lines show higher stimulated secretion than 
the A and B cell lines Table 2.  
 The secretion experiment was setup with an initial cell count of 30 k cells 
per well. The cells were grown with regular ParC5 media for six hours, and then 
the media was changed with ParC5 media containing puromycin and cumate. 
After the cells grew to ~70% confluence, the secretion harvest was performed 
with a series of washes and the basal and stimulated medias were applied and 
collected after thirty minutes consecutively. An assay was performed by loading 
20 !L of each media sample in duplicated to a 96-well microplate. Then, the 
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cypridina luciferase solvent, buffer, and substrate solutions were made and 
loaded into the luminometer and the assay was run. 
In a comparison of secretion experiments 12, 14, 15, and 18, Figure 15 
cell lines A and B show a stimulated / basal ratio of 1.1 and 0.7 respectively. In 
the same series of experiments, cell lines D, E, and E2 show a stimulated / basal 
ratio of 0.7, 0.5, and 1.25 respectively. The control cell line C, shows a ratio of 
0.7. Though the E2 cell line shows some stimulated secretion, a 1 way ANOVA 
test was performed and no significance was observed with a p-value of 0.13. 
Additionally, an unpaired one-tail T-test was performed between the average for 



















Figure 15:  The graph above shows the average of the means of the stimulated / 
basal ratios of secretion experiments 12, 14, 15, and 18. An ANOVA was 
performed and none of the cell lines showed a significant difference from the 





Verification of the expression of XBP and Mist1 in the D, E, and E2 cell lines 
 It can be determined that the piggybac vector successfully integrated both 
the puromycin resistant gene and the Cypridina-PSP gene into the genome of 
ParC10 cells because the cells grew in ParC5 media containing puromycin, and 
a Cypridina RLU signal was seen above background in all secretion experiments. 
However, XBP and Mist1 expression cannot be verified with an assay or simple 
growth means. Thus, the goal of this experiment was to verify the expression of 
XBP and Mist1 in the D, E, and E2 cell lines. 
 The A, C, D, E, and E2 cell lines were grown in T-25 flasks in ParC5 
media containing puromycin and cumate. After reaching about 70% confluence, 
the media was aspirated and the cells were harvested with TRIzol reagent and 
RNA isolation was performed. Following the RNA isolation, rtPCR was performed 
with control groups not containing the reverse transcriptase enzyme. The product 
cDNA was then amplified using PCR supermix and primers for the XBP, Mist1, 
and Cyp-PSP plasmids separately. After amplification, loading dye was added 
and the samples were loaded onto a 1% agarose gel with 1 kb DNA ladder for 
molecular weight reference. The gel was run at 140 volts for 45 minutes. 
  Figure 16 shows the 1% agarose gel containing 1kb+ DNA ladder, 
amplified cDNA, synthesized from RNA from cell lines A, D, and E2. The 
columns for cell line A show no presence of XBP or Mist1 and the negative 
control columns, reverse transcriptase enzyme was not added to the control, for 
cell line A show no amplification of genomic DNA. The columns for cell line D 
show the presence of XBP while the negative controls show no cDNA presence. 
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Lastly, the columns for cell line E2 show the presence of XBP, yet the negative 
controls show no amplification. 
 The conclusion is cell lines D and E2 do show expression of XBP RNA, as 
they should because XBP was transfected into these particular cell lines Table 2. 
Yet, cell line A does not show XBP RNA expression, as XBP was not transfected 
into this line Table 2. Nevertheless, cells lines D and E2 do not show higher 
stimulated secretion than cell line A Figure 15, even though D and E2 contain 































Figure 16:  The pictures above are from a 1% agarose gel. RNA was extracted 
from cell lines A, D, and E2, converted to cDNA and the specific transcription 
factors Mist1, XBP, and Cyp-PSP were amplified.  XBP is ~650 bp. Cell line A 































































To date, the mechanism for how cargo proteins enter the regulated 
secretory pathway is unknown. Discovering the mechanism of “protein trafficking” 
would benefit both the scientific and medical communities because the regulated 
secretory pathway is found in all major exocrine cell types. Clinically eminent 
conditions such as diabetes and xerostomia are directly associated with these 
cell types that maintain the regulated secretory pathway. Additionally, a greater 
understanding of protein trafficking could make therapeutic models more reliable. 
Current literature describes various secretory pathways in exocrine cells; 
two focal pathways for this paper being the constitutive and regulated secretory 
pathways. Our experimental model attempts to distinguish between these two 
pathways with the understanding the constitutive pathway never turns off, even 
when stimulated. Conversely, the regulated secretory pathway only turns on in 
the presence of a stimulus. With this knowledge, we designed the secretion 
experiments so we could measure both the constitutive secretion and the 
stimulated secretion and then compare the two. 
Equally important to our experimental model is the observation that PSP is 
only found in the saliva and not the blood, suggesting it only enters the apical 
regulated secretory pathway (Darling, 2012; Venkatesh, et al., 2007). While PSP 
is only found in saliva, other prominent salivary proteins such as amylase are 
found in both the saliva and blood, suggesting PSP is unique and this 
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characteristic is advantageous for our study. These findings were the result of a 
western blot analysis of rat serum; traces of amylase were found but PSP was 
not(Darling, 2012; Venkatesh, et al., 2007). With a luciferase protein attached to 
PSP, it would be only the PSP portion of the fusion protein signaling for entrance 
into the regulated secretory pathway.  Our original question was which part of the 
PSP protein is responsible for signaling the regulated secretory pathway. 
In the beginning of this research, luciferase protein Gaussia may have 
been directing the Gaussia-PSP fusion protein into the stimulated pathway on its 
own accord. It is possible that Gaussia has a sorting sequence directing itself into 
the regulated secretory pathway. To continue using Gaussia as the luciferase 
protein fused to PSP would be bias. In other words, if stimulated secretion was 
seen with Gaussia-PSP, we would not know if it was the PSP portion of the 
fusion protein directing itself into the stimulated pathway, or if it was the Gaussia 
portion directing the fusion protein into the pathway. Consequently, we switched 
the fusion luciferase protein to cypridina, which had previously not shown any 
stimulated secretion. 
Unlike Gaussia, Cypridina alone, (Cluc-2), did not show any stimulated 
secretion, so it proved to be a good negative control. The experiments following 
the switch to using Cypridina as the luciferase fused to PSP showed no 
significant stimulated secretion. So, with a good negative control, effort was 
made to push the use of Cypridina-PSP and Cluc-2 forward as the primary 
independent variables. The following experiments used Cypridina-PSP and Cluc-
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2, but had additional factors either added or changed to promote the secretion of 
the cell in some way. 
Chromoganin B (CgB), known for its role in dense secretory core granule 
(DCSG) formation was added the transfection with Cypridina-PSP (Koshimizu, et 
al., 2011). It was thought CgB would help increase DCSG formation and thus 
allow more Cypridina-PSP to enter and be stored in the DCSGs. The current 
literature shows chromogranins added to cells increases DCSG biogenesis. By 
adding Chromogranin B, a greater amount of Cypridina-PSP would be stored. 
Thus, after stimulus treatment, more Cypridina-PSP would be released and more 
stimulated secretion would be observed. Our results showed CgB did not 
increase stimulated secretion of Cypridina-PSP, nor did it increase the stimulated 
secretion of Cluc-2. Similarly, in the current literature there is evidence that 
expression of Chromogranin A, known for its involvement in DCSG synthesis, 
could not restore the regulated secretory pathway in PC12-27 cells (Kim, et al., 
2006; Malosio, Giordano, Laslop, & Meldolesi, 2004). 
Isoproterenol, the neurotransmitter epinephrine agonist used to stimulate 
the ParC10 cells, binds to #-adrenergic receptors on the cell surface. During 
passaging of the cells, trypsin is used, and it was thought the trypsin might digest 
the surface receptors. Forskolin, a #-adrenergic agonist that turns on the 
stimulated pathway intracellularly, was used instead of isoproterenol to bypass 
the possible lack of receptors on the cell surface. The hypothesis was the use of 
forskolin, as a stimulant, would allow Cypridina-PSP to show stimulated 
secretion. The results from the experiments using forskolin were negative and 
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Cypridina-PSP showed no stimulated secretion. At this point, the focus turned 
more to the ParC10 cells and their lack of differentiation.  
For the next set of experiments, we followed the same model of 
transfecting Cypridina-PSP into ParC10 cells, but instead of performing transient 
transfections, we performed stable transfections. By integrating the Cypridina-
PSP, XBP-1, and Mist1 genes into the genome of the ParC10 cells, they have 
the potential to induce some differentiation of the cells. Using stable cells was 
crucial because XBP-1 and Mist1 needed time to express and help facilitate the 
differentiation of the cells. The time frame for a transcription factors to act on and 
regulate differentiation factors is too short during transient transfections, but long 
enough during stably transfected cell secretion experiments. Additionally, the 
transfection efficiency is increased greatly because theoretically, only the stably 
transfected cells live since there is a puromycin resistance gene in the vector, 
and the antibiotic is added to the cell media.  
The hypothesis was that Cypridina-PSP would show stimulated secretion 
in the cell lines it where it was expressed, cell lines A, B, D, E, and E2. The 
results from the stable transfection secretion experiments did not show significant 
Cypridina-PSP stimulated secretion. The negative control, cell line C, did not 
show stimulated secretion. 
The stable cell lines created included cell lines with transcription factors 
thought to have important roles in differentiation of exocrine cells (Lee, et al., 
2005; Tian, et al., 2010). These transcription factors are XBP and Mist1. Both 
were included in cell lines D and E and consequently were included in the 
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isolated cell line E2. The E2 cell line is isolated because it was developed from a 
single colony of the E cells, thus each individual cell should have genes XBP-1, 
Mist1, and Cyp-PSP integrated in the same location on the chromosomes. Since 
XBP-1 and Mist1 are transcription factors found in primary rat parotid gland cells, 
their presence should help differentiate the cells in which they are expressed. 
More importantly, these factors are associated with PSP gene expression, so 
they should help bolster the regulated secretory pathway that PSP normally 
enters in primary cells. 
The hypothesis for the secretion experiments 12, 14, 15, and 18 was the 
cell lines expressing Cypridina-PSP, XBP, and Mist1 (cell lines D, E, and E2) 
would show better stimulated secretion than the cell lines expressing just 
Cypridina-PSP (cell lines A and B). The results did not show any significant 
difference between the cell lines with just Cypridina-PSP and the cell lines with 
Cypridina-PSP, XBP, and Mist1. The conclusion from this set of experiments is 
that these additional transcription factors do not help augment the regulated 
secretory pathway to the level where constitutive and stimulated secretion 
pathways are distinguishable. 
The overall conclusion to be drawn from all of the experiments performed 
for this research paper is that the ParC10 cells lack a robust regulated secretory 
pathway. Even with the addition of transcription factors and proteins known for 
their involvement in the regulated secretory process, the level of differentiation is 
too far removed from primary cells and their respective processes. An 
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immortalized parotid cell line carrying many more transcription factors and 
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